Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Molecular Characterization of SOCS1-Mediated Regulation of the GM-CSF Receptor

FY 2012-13

Summary
Juvenile myelomonocytic leukemia (JMML) is a highly aggressive cancer that affects young children. There is no cure or effective treatment for JMML, which has an average survival rate of less than 20% past three years of diagnosis. A hallmark feature that defines and underlies JMML is the inordinately increased ability of leukemic cells to grow in the presence of granulocyte macrophage-colony stimulating factor (GM-CSF), a substance produced by cells to promote cell proliferation, via an unknown mechanism. This proposal aims to provide insightful mechanistic understanding of how GM-CSF causes this increased growth potential of leukemic cells that is responsible for the pathogenesis of JMML. Ultimately, I hope that the findings in this research endeavor will contribute towards the development of better cancer therapeutics for the management of children with JMML.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
279448
Name
Kommaraju Kamya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Molecular Characterization of SOCS1-Mediated Regulation of the GM-CSF Receptor
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Gm-Csf; Jak2; Juvenile Myelomonocytic Leukemia; Socs1; Ubiquitin
Abstract
Juvenile myelomonocytic leukemia (JMML) is a highly aggressive cancer that affects young children. There is no cure or effective treatment for JMML, which has an average survival rate of less than 20% past three years of diagnosis. A hallmark feature that defines and underlies JMML is the inordinately increased ability of leukemic cells to grow in the presence of granulocyte macrophage-colony stimulating factor (GM-CSF), a substance produced by cells to promote cell proliferation, via an unknown mechanism. This proposal aims to provide insightful mechanistic understanding of how GM-CSF causes this increased growth potential of leukemic cells that is responsible for the pathogenesis of JMML. Ultimately, I hope that the findings in this research endeavor will contribute towards the development of better cancer therapeutics for the management of children with JMML.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kommaraju, Kamya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~